Testing Status of beta-Thioguanidine deoxyriboside C01581
CASRN: 789-61-7
Formula: C10-H13-N5-O3-S
Synonyms/Common Names
- beta-TGdR
- 2'-Deoxy-6-thioguanosine (9CI)
Short-Term Toxicity
- 14-Day (Intraperitoneal Injection)
(C01581)
Completed
- Rats: Sprague Dawley; Mice: B6C3F1
- 13-Week (Intraperitoneal Injection)
(C01581)
Completed
- Rats: Sprague Dawley; Mice: B6C3F1
- Dose: R: 0, 3, 60, M: 0, .38, 3 MG/KG/5 PER GROUP.
Long-Term Carcinogenicity
- 2-Year (Intraperitoneal Injection)
(C01581)
Completed
- TR-057 (NIH Number: 78-1363)
(Peer Review Approval 02/18/1978A )
Bioassay of ß-TGdR for Possible Carcinogenicity (CASRN 789-61-7) - Rats: Sprague Dawley; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Equivocal
- Female Rats Positive
- Male Mice Inadequate Study
- Female Mice Inadequate Study
- Dose: R: 0, 3.5, 7, M: 0, 1, 4 MG/KG/35 PER GROUP.
- TR-057 (NIH Number: 78-1363)
(Peer Review Approval 02/18/1978A )